•   
  •   
  •   

World UN authorizes AstraZeneca's COVID vaccine for emergency use

22:46  15 february  2021
22:46  15 february  2021 Source:   msn.com

The Latest: China gives broader approval for Sinovac vaccine

  The Latest: China gives broader approval for Sinovac vaccine TAIPEI, Taiwan — China has given broader approval for the domestic-made Sinovac coronavirus vaccine. The decision on the Sinovac vaccine was announced Saturday. It expands who can receive the vaccine beyond the high-risk and priority groups already allowed under an emergency clearance. The Sinovac vaccine has already been sold to at least 10 other countries and is being administered to people in at least five other countries. In China, the shot was given emergency approval last July, allowing groups such as medical workers and employees of state-owned firms to receive it. The conditional approval means the vaccine now can be given to the general public.

TORONTO (AP) — The World Health Organization has granted an emergency authorization to AstraZeneca's coronavirus vaccine, a move that should allow the U.N. agency's partners to ship millions of doses to countries worldwide as part of a U.N.-backed program to tame the pandemic.

Britain's Prime Minister Boris Johnson holds a vial of the AstraZeneca vaccine during a visit to a coronavirus vaccination centre at the Health and Well-being Centre in Orpington, south-east London, Monday, Feb. 15, 2021. (Jeremy Selwyn/Pool Photo via AP) © Provided by Associated Press Britain's Prime Minister Boris Johnson holds a vial of the AstraZeneca vaccine during a visit to a coronavirus vaccination centre at the Health and Well-being Centre in Orpington, south-east London, Monday, Feb. 15, 2021. (Jeremy Selwyn/Pool Photo via AP)

In a statement Monday, the WHO said it was clearing the AstraZeneca vaccines made by the Serum Institute of India and South Korea’s AstraZeneca-SKBio.

Giving plasma, chicken robbery, bar-free Mardi Gras: News from around our 50 states

  Giving plasma, chicken robbery, bar-free Mardi Gras: News from around our 50 states How the COVID-19 pandemic is affecting every stateStart the day smarter. Get all the news you need in your inbox each morning.

The WHO’s green light for the AstraZeneca vaccine is only the second one the U.N. health agency has issued after authorizing the Pfizer-BioNTech vaccine in December. Monday's announcement should trigger the delivery of hundreds of millions of doses to countries that have signed up for the U.N.-backed COVAX effort, which aims to deliver vaccines to the world’s most vulnerable people.

“Countries with no access to vaccines to date will finally be able to start vaccinating their health workers and populations at risk,” said Dr Mariângela Simão, the WHO's Assistant-Director General for Access to Medicines and Health Products.

The coronavirus pandemic has infected about 109 million people worldwide and killed at least 2.4 million of them. But many of the world's countries have not yet started vaccination programs and even rich nations are facing shortages of vaccine doses as manufacturers struggle to ramp up production.

South Africa halts AstraZeneca vaccine plan over study data

  South Africa halts AstraZeneca vaccine plan over study data Trial shows Oxford-developed COVID-19 vaccine offers only "minimal" protection against mild to moderate illness from South Africa variant. A trial showed the vaccine, developed by AstraZeneca and Oxford University, provides only "minimal" protection against mild to moderate COVID-19 infection caused specifically by the variant that has swept through South Africa. The strain, believed to be more easily transmitted but not to cause significantly more serious illness, has also been detected in the U.S., the U.K. and other nations, but is not believed to be the dominant variant in circulation.

The AstraZeneca vaccine has already been authorized in more than 50 countries, including Britain, India, Argentina and Mexico. It is cheaper and easier to handle than the Pfizer-BioNTech vaccine, which needs deep cold storage that is not widespread in many developing nations. Both vaccines require two shots per person, given weeks apart.

Last week, WHO vaccine experts recommended the use of the AstraZeneca vaccine for people over age 18, including in countries that have detected variants of COVID-19.

But that was contrary to the recommendation from the African Centers for Disease Control and Prevention, which said countries that had identified a virus variant first seen in South Africa should be “cautious” in their use of the AstraZeneca vaccine, suggesting that other shots be prioritized instead.

The AstraZeneca vaccine forms the bulk of COVAX’s current stockpile and concerns were recently raised after an early study suggested it might not prevent mild and moderate disease caused by the variant first seen South Africa. Last week, South Africa scaled back its planned rollout of the AstraZeneca vaccine, opting instead to use an unlicensed shot from Johnson & Johnson for its health care workers.

Use AstraZeneca's COVID-19 shot even in countries with S.African variant, says WHO panel

  Use AstraZeneca's COVID-19 shot even in countries with S.African variant, says WHO panel Use AstraZeneca's COVID-19 shot even in countries with S.African variant, says WHO panelGENEVA, Feb 10 (Reuters) - AstraZeneca's COVID-19 vaccine is safe and effective and should be deployed widely, including in countries where the South African variant of the coronavirus may reduce its efficacy, a World Health Organization panel said on Wednesday.

COVAX has already missed its own goal of beginning coronavirus vaccinations in poor countries at the same time that shots were rolled out in rich countries. Numerous developing countries have rushed in recent weeks to sign their own private deals to buy vaccines, unwilling to wait for COVAX.

WHO and its partners, including the vaccines alliance GAVI, have not said which countries will receive the first doses from COVAX. But an initial plan showed a handful of rich countries that have signed multiple private vaccine deals, including Canada, South Korea and New Zealand, are also scheduled to receive early doses from COVAX.

Some public health experts called that “very problematic” and attributed it to COVAX’s flawed design, which allowed donor countries to double dip by purchasing vaccines from the program while also signing their own commercial deals.

“Canada has ordered enough doses to supply their population about five times over and now they’re looking to accept their share of doses from COVAX, which would otherwise be given to poor nations,” said Anna Marriott, health policy lead for Oxfam International.

The world's pandemic exit plan hits a snag

  The world's pandemic exit plan hits a snag A group of experts will present their recommendations to the World Health Organization on Tuesday on how countries should be using AstraZeneca's Covid-19 vaccine, following a study that suggested it offered limited protection against a variant first identified in South Africa. © Reuters CDC releases illustration of the Coronavirus. South Africa delayed the rollout of the vaccine on the weekend following publication of early data in the study, which found the shot offered "minimal protection" against mild to moderate disease in the South African variant.

WHO chief scientist Dr. Soumya Swaminathan has said rich countries that have signed up to receive vaccines from COVAX won’t have their requests denied.

“The COVAX facility is not going to penalize countries,” she said in early February.

After pledging more than $400 million to COVAX last year, Canadian Prime Minister Justin Trudeau said it was always his country’s intention to get vaccines through COVAX.

Marriott said rich countries planning to take doses from COVAX should reconsider their intentions, given their earlier calls of support for the effort’s goal of equal access to vaccines for all the world's nations, rich or poor.

“It seems quite hypocritical,” she said. "Rich countries with their own supplies should make the right call and not take vaccines from countries who are really in a dire situation.”

___

This story corrects that doses will be shipped by the WHO's partners, not AstraZeneca's partners.

___

Follow all of AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic, https://apnews.com/hub/coronavirus-vaccine and https://apnews.com/UnderstandingtheOutbreak

Bloody Sunday plans, defining pandemics, teacher dilemmas: News from around our 50 states .
How the COVID-19 pandemic is affecting every stateStart the day smarter. Get all the news you need in your inbox each morning.

usr: 1
This is interesting!